Activation of extracellular signal-regulated kinases (ERK) 1/2 in dorsal horn neurons is important for the development of somatic hypersensitivity and spinal central sensitization after peripheral inflammation. However, data regarding the roles of spinal ERK1/2 in the development of visceral hyperalgesia are sparse. Here we studied the activation of ERK1/2 in the lumbosacral spinal cord after innocuous and noxious distention of the inflamed (cyclophosphamide-treated) and noninflamed urinary bladder in mice. We also correlated the spinal ERK1/2 activation to distention-evoked bladder nociception as quantified by the abdominal visceromotor response (VMR). Cyclophosphamide treatment (bladder inflammation) evoked increased bladder hyperalgesia and allodynia to bladder distention, as evident from an upward and leftward shift of the VMR stimulus-response curve compared with that of noninflamed mice. Development of bladder hyperalgesia was associated with robust enhancement of ERK1/2 activation in the dorsal horn and deeper laminae bilaterally in the L6-S1 spinal cord. Functional blockade of spinal ERK1/2 activity via intrathecal administration of the upstream MEK inhibitor U0126 attenuated distentionevoked bladder nociception and caused a significant downward shift of the VMR stimulus-response curve. In summary, we have provided functional and immunohistochemical evidence that activation of lumbosacral spinal ERK1/2 is associated with the development of primary visceral (bladder) hyperalgesia. Our results suggest that aberrant processing of visceral nociceptive information at the level of the lumbosacral spinal cord via activation of ERK1/2 signaling may contribute to chronic bladder pain in the context of inflammation.
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Introduction
Extracellular signal-regulated kinases (ERK) belong to a family of serine/threonine kinases (mitogen-activated protein kinases, MAPK) that regulate intracellular signal transduction to a variety of stimuli [13, 35] . Activation of ERK (by phosphorylation) via MAPK/ERK kinase (MEK) leads to the regulation of gene transcription [6, 12, 24] as well as acute posttranslational changes such as phosphorylation of ion channels [1, 17, 18] . In the nervous system, these neuromodulatory effects may contribute to long-term changes in neural plasticity [22] . Recent evidence suggests that ERK signaling also modulates nociceptive processing in somatic pain models [25] . After noxious stimulation of the hind paw (eg, with formalin-induced inflammation), ERK1 and ERK2 are rapidly activated in dorsal horn neurons [2, 15, 23, 27, 28] . ERK activation leads to phosphorylation and modulation of K v 4.2-containing ion channels, increased dorsal horn neuronal excitability, and spinal central sensitization. Blockade of ERK1/2 activity attenuates mechanical hyperalgesia and spinal neuronal hyperexcitability that is induced in the context of acute or persistent inflammation [2, [17] [18] [19] [20] 26, 27] .
Previous studies have shown that spinal ERK1/2 activation is associated with the development of somatic hyperalgesia and central sensitization after peripheral inflammation. However, data regarding the potential roles of spinal phospho-ERK1/2 in the development of visceral hyperalgesia are sparse. In a colon inflammation model, ERK1/2 activation is associated with the development of secondary mechanical hyperalgesia of the abdominal wall 
